Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine
Open Access
- 7 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Parasitenkunde
- Vol. 105 (6), 1767-1777
- https://doi.org/10.1007/s00436-009-1646-z
Abstract
Advent of an effective schistosome vaccine would contribute significantly toward reducing the disease spectrum and transmission of schistosomiasis. We have targeted a functionally important antigen, Sm-p80, as a vaccine candidate because of its consistent immunogenicity, protective and antifecundity potentials, and important role in the immune evasion process. In this study, we report that using two vaccination approaches (prime boost and recombinant protein), Sm-p80-based vaccine formulation(s) confer up to 70% reduction in worm burden in mice. Animals immunized with the vaccine exhibited a decrease in egg production by up to 75%. The vaccine elicited strong immune responses that included IgM, IgA, and IgG (IgG1, IgG2a, IgG2b, and IgG3) in vaccinated animals. Splenocytes proliferated in response to Sm-p80 produced Th1 and Th17 response enhancing cytokines. These results again emphasize the potential of Sm-p80 as a viable vaccine candidate for schistosomiasis.Keywords
This publication has 48 references indexed in Scilit:
- Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate modelVaccine, 2009
- Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoniParasite Immunology, 2008
- Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?PLoS Neglected Tropical Diseases, 2008
- Trick or Treat: The Role of Vaccines in Integrated Schistosomiasis ControlPLoS Neglected Tropical Diseases, 2008
- T Cells Help To Amplify Inflammatory Responses Induced bySalmonella entericaSerotype Typhimurium in the Intestinal MucosaInfection and Immunity, 2008
- Experimental vaccines in animal models for schistosomiasisZeitschrift für Parasitenkunde, 2008
- Current Status of Vaccines for SchistosomiasisClinical Microbiology Reviews, 2008
- Immunopathology of schistosomiasisImmunology & Cell Biology, 2006
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006
- Combination Chemotherapy of Schistosomiasis in Laboratory Studies and Clinical TrialsAntimicrobial Agents and Chemotherapy, 2003